SCHEMBL6397669

SCHEMBL6397669

CC(c1cccc(O)c1)C(O)(O)c1c(O)cc(O)cc1OP(=O)(O)O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 2/20 0.37
HTR2A P28223 2/20 0.37
ADRA1A P35348 2/20 0.37
MIF P14174 1/20 0.37
HTR2B P41595 1/20 0.37
KDM4E B2RXH2 2/20 0.34
HIF1A Q16665 2/20 0.34
LMNA P02545 1/20 0.34
INPPL1 O15357 3/20 0.34
INPP5A Q14642 3/20 0.34
INPP5B P32019 2/20 0.34
POLB P06746 1/20 0.33
ALDH1A1 P00352 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
HSD17B10 Q99714 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
TYR P14679 1/20 0.31
MAPKAPK2 P49137 1/20 0.31
ESR1 P03372 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6398644 0.89 INPPL1 (0.38) ADRB1HTR2AADRA1AMIFHTR2B
SCHEMBL6398701 0.88 INPPL1 (0.35) KDM4EINPPL1INPP5AINPP5BMAPT
SCHEMBL6397576 0.85 SLC22A1 (0.33) ADRB1HTR2AADRA1AMIFHTR2B
SCHEMBL6397701 0.83 INPPL1 (0.36) ADRB1HTR2AADRA1AMIFHTR2B
SCHEMBL6398583 0.83 ADRB1 (0.35) ADRB1HTR2AADRA1AMIFHTR2B
SCHEMBL6404462 0.81 ADRB1 (0.39) ADRB1HTR2AADRA1AMIFHTR2B
SCHEMBL6395800 0.81 INPPL1 (0.36) ADRB1HTR2AADRA1AMIFHTR2B
SCHEMBL6404456 0.79 ADRB1 (0.37) ADRB1HTR2AADRA1AMIFHTR2B
SCHEMBL7617241 0.78 INPPL1 (0.37) ADRB1HTR2AADRA1AMIFHTR2B
SCHEMBL6396330 0.78 INPPL1 (0.41) HTR2AHTR2BKDM4EINPPL1INPP5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050187195-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans PEERCE BRIAN E (US) 2005-08-25 US disclosed
US-6787528-B2 THERAPY FOR KIDNEY DISEASES BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2004-09-07 US disclosed
US-20030162753-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2003-08-28 US disclosed
US-20020133036-A1 Inhibitors of intestinal apical membrane Na/phosphate co-transportation PEERCE BRIAN E (US) 2002-09-19 US disclosed
US-6355823-B1 MEMBRANE SUBSTRATE PHOSPHATED FOR DRUGS FOR GASTROINTESTINAL DISORDERS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2002-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187195-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans SLC34A3, SLC34A1, SLC34A2 ADRB1 1543/4885HTR2A 2756/4885ADRA1A 2552/4885
US-20020133036-A1 Inhibitors of intestinal apical membrane Na/phosphate co-transportation SLC10A2, SLC34A3, SLC34A1 ADRB1 1645/4885HTR2A 2925/4885ADRA1A 2707/4885
US-20030162753-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans SLC34A3, SLC34A1, SLC34A2 ADRB1 1543/4885HTR2A 2756/4885ADRA1A 2552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.